Type:Notice
Citation:90 FR 13886
Reading Time:about 2 minutes
The Drug Enforcement Administration (DEA) has announced that Ohana Bio Pharma, LLC has applied to be registered as a bulk manufacturer of controlled substances in schedule I, specifically for marihuana. This application is part of a program to grow marihuana for scientific and medical research. The DEA will evaluate the application according to its regulations to ensure legal compliance and prevent any misuse. Interested parties can submit their comments or objections by May 27, 2025, through the Federal eRulemaking Portal.
Simple Explanation
The government is thinking about letting a company, Ohana Bio Pharma, LLC, grow a special plant called marihuana for studying and medicine. They want to know what people think about this by May 27, 2025.